Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Influenza Vaccines Market 2018, Forecast to 2023

July 2018 | 145 pages | ID: G5F9CFEFCF1GEN
GlobalInfoResearch

Abstracts

Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. The CDC estimates that vaccination against influenza reduces sickness, medical visits, hospitalizations, and deaths. When an immunized worker does catch the flu, they are on average back at work a half day sooner. Vaccine effectiveness in those under two years old and over 65 years old remains unknown due to the low quality of the research. needs update][8][needs update] Vaccinating children may protect those around them.
The World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) recommend yearly vaccination for nearly all people over the age of six months, especially those at high risk. The European Centre for Disease Prevention and Control also recommends yearly vaccination of high risk groups. These groups include pregnant women, the elderly, children between six months and five years of age, those with other health problems, and those who work in healthcare.
The vaccines are generally safe. Fever occurs in five to ten percent of children vaccinated. Temporary muscle pains or feelings of tiredness may occur as well. In certain years, the vaccine has been linked to an increase in Guillain?Barr? syndrome among older people at a rate of about one case per million doses. It should not be given to those with severe allergies to eggs or to previous versions of the vaccine. The vaccines come in both inactive and weakened viral forms. The inactive version should be used for those who are pregnant. They come in forms that are injected into a muscle, sprayed into the nose, or injected into the middle layer of the skin.
Vaccination against influenza began in the 1930s with large scale availability in the United States beginning in 1945. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale price in the developing world is about $5.25 USD per dose as of 2014.In the United States, it costs less than $25 USD as of 2015.

SCOPE OF THE REPORT:

This report focuses on the Influenza Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Influenza Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• AstraZeneca
• CSL
• GlaxoSmithKline
• Sanofi
• Altimmune
• BionVax
• FluGen
• FOLIA BIOTECH
• Genentech
• Green Cross
• Medicago
• Moderna Therapeutics
• Novavax
• Shijiazhuang Yiling Pharmaceutical
• SK Chemicals
• UNM Pharma
• Vaccitech
• Vaxart
• Vaxine Pty
• Visterra

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Trivalent Flu Vaccines
• Quadrivalent Flu Vaccines

Market Segment by Applications, can be divided into

• Adults
• Pediatrics

There are 15 Chapters to deeply display the global Influenza Vaccines market.

Chapter 1, to describe Influenza Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Influenza Vaccines, with sales, revenue, and price of Influenza Vaccines, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Influenza Vaccines, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Influenza Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Influenza Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Influenza Vaccines Introduction
1.2 Market Analysis by Type
  1.2.1 Trivalent Flu Vaccines
  1.2.2 Quadrivalent Flu Vaccines
1.3 Market Analysis by Applications
  1.3.1 Adults
  1.3.2 Pediatrics
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 AstraZeneca
  2.1.1 Business Overview
    2.1.1.1 AstraZeneca Description
    2.1.1.2 AstraZeneca Headquarter, Main Business and Finance Overview
  2.1.2 AstraZeneca Influenza Vaccines Product Introduction
    2.1.2.1 Influenza Vaccines Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Influenza Vaccines Product Information
  2.1.3 AstraZeneca Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.1 AstraZeneca Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Global AstraZeneca Influenza Vaccines Market Share in 2017
2.2 CSL
  2.2.1 Business Overview
    2.2.1.1 CSL Description
    2.2.1.2 CSL Headquarter, Main Business and Finance Overview
  2.2.2 CSL Influenza Vaccines Product Introduction
    2.2.2.1 Influenza Vaccines Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Influenza Vaccines Product Information
  2.2.3 CSL Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.1 CSL Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Global CSL Influenza Vaccines Market Share in 2017
2.3 GlaxoSmithKline
  2.3.1 Business Overview
    2.3.1.1 GlaxoSmithKline Description
    2.3.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
  2.3.2 GlaxoSmithKline Influenza Vaccines Product Introduction
    2.3.2.1 Influenza Vaccines Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Influenza Vaccines Product Information
  2.3.3 GlaxoSmithKline Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.1 GlaxoSmithKline Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Global GlaxoSmithKline Influenza Vaccines Market Share in 2017
2.4 Sanofi
  2.4.1 Business Overview
    2.4.1.1 Sanofi Description
    2.4.1.2 Sanofi Headquarter, Main Business and Finance Overview
  2.4.2 Sanofi Influenza Vaccines Product Introduction
    2.4.2.1 Influenza Vaccines Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Influenza Vaccines Product Information
  2.4.3 Sanofi Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.1 Sanofi Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Global Sanofi Influenza Vaccines Market Share in 2017
2.5 Altimmune
  2.5.1 Business Overview
    2.5.1.1 Altimmune Description
    2.5.1.2 Altimmune Headquarter, Main Business and Finance Overview
  2.5.2 Altimmune Influenza Vaccines Product Introduction
    2.5.2.1 Influenza Vaccines Production Bases, Sales Regions and Major Competitors
    2.5.2.2 Influenza Vaccines Product Information
  2.5.3 Altimmune Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.1 Altimmune Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 Global Altimmune Influenza Vaccines Market Share in 2017
2.6 BionVax
  2.6.1 Business Overview
    2.6.1.1 BionVax Description
    2.6.1.2 BionVax Headquarter, Main Business and Finance Overview
  2.6.2 BionVax Influenza Vaccines Product Introduction
    2.6.2.1 Influenza Vaccines Production Bases, Sales Regions and Major Competitors
    2.6.2.2 Influenza Vaccines Product Information
  2.6.3 BionVax Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.1 BionVax Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 Global BionVax Influenza Vaccines Market Share in 2017
2.7 FluGen
  2.7.1 Business Overview
    2.7.1.1 FluGen Description
    2.7.1.2 FluGen Headquarter, Main Business and Finance Overview
  2.7.2 FluGen Influenza Vaccines Product Introduction
    2.7.2.1 Influenza Vaccines Production Bases, Sales Regions and Major Competitors
    2.7.2.2 Influenza Vaccines Product Information
  2.7.3 FluGen Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.1 FluGen Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.2 Global FluGen Influenza Vaccines Market Share in 2017
2.8 FOLIA BIOTECH
  2.8.1 Business Overview
    2.8.1.1 FOLIA BIOTECH Description
    2.8.1.2 FOLIA BIOTECH Headquarter, Main Business and Finance Overview
  2.8.2 FOLIA BIOTECH Influenza Vaccines Product Introduction
    2.8.2.1 Influenza Vaccines Production Bases, Sales Regions and Major Competitors
    2.8.2.2 Influenza Vaccines Product Information
  2.8.3 FOLIA BIOTECH Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.1 FOLIA BIOTECH Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.2 Global FOLIA BIOTECH Influenza Vaccines Market Share in 2017
2.9 Genentech
  2.9.1 Business Overview
    2.9.1.1 Genentech Description
    2.9.1.2 Genentech Headquarter, Main Business and Finance Overview
  2.9.2 Genentech Influenza Vaccines Product Introduction
    2.9.2.1 Influenza Vaccines Production Bases, Sales Regions and Major Competitors
    2.9.2.2 Influenza Vaccines Product Information
  2.9.3 Genentech Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.1 Genentech Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.2 Global Genentech Influenza Vaccines Market Share in 2017
2.10 Green Cross
  2.10.1 Business Overview
    2.10.1.1 Green Cross Description
    2.10.1.2 Green Cross Headquarter, Main Business and Finance Overview
  2.10.2 Green Cross Influenza Vaccines Product Introduction
    2.10.2.1 Influenza Vaccines Production Bases, Sales Regions and Major Competitors
    2.10.2.2 Influenza Vaccines Product Information
  2.10.3 Green Cross Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.1 Green Cross Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.2 Global Green Cross Influenza Vaccines Market Share in 2017
2.11 Medicago
  2.11.1 Business Overview
  2.11.2 Medicago Influenza Vaccines Product Introduction
  2.11.3 Medicago Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Moderna Therapeutics
  2.12.1 Business Overview
  2.12.2 Moderna Therapeutics Influenza Vaccines Product Introduction
  2.12.3 Moderna Therapeutics Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Novavax
  2.13.1 Business Overview
  2.13.2 Novavax Influenza Vaccines Product Introduction
  2.13.3 Novavax Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Shijiazhuang Yiling Pharmaceutical
  2.14.1 Business Overview
  2.14.2 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product Introduction
  2.14.3 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 SK Chemicals
  2.15.1 Business Overview
  2.15.2 SK Chemicals Influenza Vaccines Product Introduction
  2.15.3 SK Chemicals Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 UNM Pharma
  2.16.1 Business Overview
  2.16.2 UNM Pharma Influenza Vaccines Product Introduction
  2.16.3 UNM Pharma Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Vaccitech
  2.17.1 Business Overview
  2.17.2 Vaccitech Influenza Vaccines Product Introduction
  2.17.3 Vaccitech Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Vaxart
  2.18.1 Business Overview
  2.18.2 Vaxart Influenza Vaccines Product Introduction
  2.18.3 Vaxart Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Vaxine Pty
  2.19.1 Business Overview
  2.19.2 Vaxine Pty Influenza Vaccines Product Introduction
  2.19.3 Vaxine Pty Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Visterra
  2.20.1 Business Overview
  2.20.2 Visterra Influenza Vaccines Product Introduction
  2.20.3 Visterra Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL INFLUENZA VACCINES MARKET COMPETITION, BY MANUFACTURER

3.1 Global Influenza Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Influenza Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Influenza Vaccines Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Influenza Vaccines Manufacturer Market Share in 2017
  3.4.2 Top 5 Influenza Vaccines Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL INFLUENZA VACCINES MARKET ANALYSIS BY REGIONS

4.1 Global Influenza Vaccines Sales, Revenue and Market Share by Regions
  4.1.1 Global Influenza Vaccines Sales by Regions (2013-2018)
  4.1.2 Global Influenza Vaccines Revenue by Regions (2013-2018)
4.2 North America Influenza Vaccines Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Influenza Vaccines Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Influenza Vaccines Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Influenza Vaccines Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Influenza Vaccines Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA INFLUENZA VACCINES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Influenza Vaccines Sales, Revenue and Market Share by Countries
  5.1.1 North America Influenza Vaccines Sales by Countries (2013-2018)
  5.1.2 North America Influenza Vaccines Revenue by Countries (2013-2018)
  5.1.3 United States Influenza Vaccines Sales and Growth Rate (2013-2018)
  5.1.4 Canada Influenza Vaccines Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Influenza Vaccines Sales and Growth Rate (2013-2018)
5.2 North America Influenza Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Influenza Vaccines Sales by Manufacturers (2016-2017)
  5.2.2 North America Influenza Vaccines Revenue by Manufacturers (2016-2017)
5.3 North America Influenza Vaccines Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Influenza Vaccines Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Influenza Vaccines Revenue and Revenue Share by Type (2013-2018)
5.4 North America Influenza Vaccines Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Influenza Vaccines Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Influenza Vaccines Revenue and Revenue Share by Application (2013-2018)

6 EUROPE INFLUENZA VACCINES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Influenza Vaccines Sales, Revenue and Market Share by Countries
  6.1.1 Europe Influenza Vaccines Sales by Countries (2013-2018)
  6.1.2 Europe Influenza Vaccines Revenue by Countries (2013-2018)
  6.1.3 Germany Influenza Vaccines Sales and Growth Rate (2013-2018)
  6.1.4 UK Influenza Vaccines Sales and Growth Rate (2013-2018)
  6.1.5 France Influenza Vaccines Sales and Growth Rate (2013-2018)
  6.1.6 Russia Influenza Vaccines Sales and Growth Rate (2013-2018)
  6.1.7 Italy Influenza Vaccines Sales and Growth Rate (2013-2018)
6.2 Europe Influenza Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Influenza Vaccines Sales by Manufacturers (2016-2017)
  6.2.2 Europe Influenza Vaccines Revenue by Manufacturers (2016-2017)
6.3 Europe Influenza Vaccines Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Influenza Vaccines Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Influenza Vaccines Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Influenza Vaccines Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Influenza Vaccines Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Influenza Vaccines Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC INFLUENZA VACCINES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Influenza Vaccines Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Influenza Vaccines Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Influenza Vaccines Revenue by Countries (2013-2018)
  7.1.3 China Influenza Vaccines Sales and Growth Rate (2013-2018)
  7.1.4 Japan Influenza Vaccines Sales and Growth Rate (2013-2018)
  7.1.5 Korea Influenza Vaccines Sales and Growth Rate (2013-2018)
  7.1.6 India Influenza Vaccines Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Influenza Vaccines Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Influenza Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Influenza Vaccines Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Influenza Vaccines Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Influenza Vaccines Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Influenza Vaccines Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Influenza Vaccines Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Influenza Vaccines Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Influenza Vaccines Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Influenza Vaccines Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA INFLUENZA VACCINES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Influenza Vaccines Sales, Revenue and Market Share by Countries
  8.1.1 South America Influenza Vaccines Sales by Countries (2013-2018)
  8.1.2 South America Influenza Vaccines Revenue by Countries (2013-2018)
  8.1.3 Brazil Influenza Vaccines Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Influenza Vaccines Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Influenza Vaccines Sales and Growth Rate (2013-2018)
8.2 South America Influenza Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Influenza Vaccines Sales by Manufacturers (2016-2017)
  8.2.2 South America Influenza Vaccines Revenue by Manufacturers (2016-2017)
8.3 South America Influenza Vaccines Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Influenza Vaccines Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Influenza Vaccines Revenue and Revenue Share by Type (2013-2018)
8.4 South America Influenza Vaccines Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Influenza Vaccines Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Influenza Vaccines Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA INFLUENZA VACCINES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Influenza Vaccines Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Influenza Vaccines Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Influenza Vaccines Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Influenza Vaccines Sales and Growth Rate (2013-2018)
  9.1.4 UAE Influenza Vaccines Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Influenza Vaccines Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Influenza Vaccines Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Influenza Vaccines Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Influenza Vaccines Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Influenza Vaccines Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Influenza Vaccines Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Influenza Vaccines Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Influenza Vaccines Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Influenza Vaccines Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Influenza Vaccines Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Influenza Vaccines Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Influenza Vaccines Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL INFLUENZA VACCINES MARKET SEGMENT BY TYPE

10.1 Global Influenza Vaccines Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Influenza Vaccines Sales and Market Share by Type (2013-2018)
  10.1.2 Global Influenza Vaccines Revenue and Market Share by Type (2013-2018)
10.2 Trivalent Flu Vaccines Sales Growth and Price
  10.2.1 Global Trivalent Flu Vaccines Sales Growth (2013-2018)
  10.2.2 Global Trivalent Flu Vaccines Price (2013-2018)
10.3 Quadrivalent Flu Vaccines Sales Growth and Price
  10.3.1 Global Quadrivalent Flu Vaccines Sales Growth (2013-2018)
  10.3.2 Global Quadrivalent Flu Vaccines Price (2013-2018)

11 GLOBAL INFLUENZA VACCINES MARKET SEGMENT BY APPLICATION

11.1 Global Influenza Vaccines Sales Market Share by Application (2013-2018)
11.2 Adults Sales Growth (2013-2018)
11.3 Pediatrics Sales Growth (2013-2018)

12 INFLUENZA VACCINES MARKET FORECAST (2018-2023)

12.1 Global Influenza Vaccines Sales, Revenue and Growth Rate (2018-2023)
12.2 Influenza Vaccines Market Forecast by Regions (2018-2023)
  12.2.1 North America Influenza Vaccines Market Forecast (2018-2023)
  12.2.2 Europe Influenza Vaccines Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Influenza Vaccines Market Forecast (2018-2023)
  12.2.4 South America Influenza Vaccines Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Influenza Vaccines Market Forecast (2018-2023)
12.3 Influenza Vaccines Market Forecast by Type (2018-2023)
  12.3.1 Global Influenza Vaccines Sales Forecast by Type (2018-2023)
  12.3.2 Global Influenza Vaccines Market Share Forecast by Type (2018-2023)
12.4 Influenza Vaccines Market Forecast by Application (2018-2023)
  12.4.1 Global Influenza Vaccines Sales Forecast by Application (2018-2023)
  12.4.2 Global Influenza Vaccines Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Influenza Vaccines Picture
Table Product Specifications of Influenza Vaccines
Figure Global Influenza Vaccines CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Influenza Vaccines CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Influenza Vaccines by Types in 2017
Figure Trivalent Flu Vaccines Picture
Table Major Manufacturers of Trivalent Flu Vaccines
Figure Quadrivalent Flu Vaccines Picture
Table Major Manufacturers of Quadrivalent Flu Vaccines
Figure Influenza Vaccines Sales Market Share by Applications in 2017
Figure Adults Picture
Figure Pediatrics Picture
Figure United States Influenza Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Influenza Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Influenza Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Influenza Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure France Influenza Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure UK Influenza Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Influenza Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Influenza Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure China Influenza Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Influenza Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Influenza Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure India Influenza Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Influenza Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Influenza Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Influenza Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Influenza Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Influenza Vaccines Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Influenza Vaccines Revenue (Value) and Growth Rate (2013-2023)
Table AstraZeneca Headquarter, Established, Main Business and Finance Overview (2017)
Table AstraZeneca Influenza Vaccines Production Bases, Sales Regions and Major Competitors
Table AstraZeneca Influenza Vaccines Product
Table AstraZeneca Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AstraZeneca Influenza Vaccines Sales Market Share in 2017
Figure Global AstraZeneca Influenza Vaccines Revenue Market Share in 2017
Table CSL Headquarter, Established, Main Business and Finance Overview (2017)
Table CSL Influenza Vaccines Production Bases, Sales Regions and Major Competitors
Table CSL Influenza Vaccines Product
Table CSL Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global CSL Influenza Vaccines Sales Market Share in 2017
Figure Global CSL Influenza Vaccines Revenue Market Share in 2017
Table GlaxoSmithKline Headquarter, Established, Main Business and Finance Overview (2017)
Table GlaxoSmithKline Influenza Vaccines Production Bases, Sales Regions and Major Competitors
Table GlaxoSmithKline Influenza Vaccines Product
Table GlaxoSmithKline Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GlaxoSmithKline Influenza Vaccines Sales Market Share in 2017
Figure Global GlaxoSmithKline Influenza Vaccines Revenue Market Share in 2017
Table Sanofi Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Influenza Vaccines Production Bases, Sales Regions and Major Competitors
Table Sanofi Influenza Vaccines Product
Table Sanofi Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Influenza Vaccines Sales Market Share in 2017
Figure Global Sanofi Influenza Vaccines Revenue Market Share in 2017
Table Altimmune Headquarter, Established, Main Business and Finance Overview (2017)
Table Altimmune Influenza Vaccines Production Bases, Sales Regions and Major Competitors
Table Altimmune Influenza Vaccines Product
Table Altimmune Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Altimmune Influenza Vaccines Sales Market Share in 2017
Figure Global Altimmune Influenza Vaccines Revenue Market Share in 2017
Table BionVax Headquarter, Established, Main Business and Finance Overview (2017)
Table BionVax Influenza Vaccines Production Bases, Sales Regions and Major Competitors
Table BionVax Influenza Vaccines Product
Table BionVax Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global BionVax Influenza Vaccines Sales Market Share in 2017
Figure Global BionVax Influenza Vaccines Revenue Market Share in 2017
Table FluGen Headquarter, Established, Main Business and Finance Overview (2017)
Table FluGen Influenza Vaccines Production Bases, Sales Regions and Major Competitors
Table FluGen Influenza Vaccines Product
Table FluGen Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global FluGen Influenza Vaccines Sales Market Share in 2017
Figure Global FluGen Influenza Vaccines Revenue Market Share in 2017
Table FOLIA BIOTECH Headquarter, Established, Main Business and Finance Overview (2017)
Table FOLIA BIOTECH Influenza Vaccines Production Bases, Sales Regions and Major Competitors
Table FOLIA BIOTECH Influenza Vaccines Product
Table FOLIA BIOTECH Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global FOLIA BIOTECH Influenza Vaccines Sales Market Share in 2017
Figure Global FOLIA BIOTECH Influenza Vaccines Revenue Market Share in 2017
Table Genentech Headquarter, Established, Main Business and Finance Overview (2017)
Table Genentech Influenza Vaccines Production Bases, Sales Regions and Major Competitors
Table Genentech Influenza Vaccines Product
Table Genentech Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Genentech Influenza Vaccines Sales Market Share in 2017
Figure Global Genentech Influenza Vaccines Revenue Market Share in 2017
Table Green Cross Headquarter, Established, Main Business and Finance Overview (2017)
Table Green Cross Influenza Vaccines Production Bases, Sales Regions and Major Competitors
Table Green Cross Influenza Vaccines Product
Table Green Cross Influenza Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Green Cross Influenza Vaccines Sales Market Share in 2017
Figure Global Green Cross Influenza Vaccines Revenue Market Share in 2017
Table Medicago
Table Medicago Influenza Vaccines
Table Moderna Therapeutics
Table Moderna Therapeutics Influenza Vaccines
Table Novavax
Table Novavax Influenza Vaccines
Table Shijiazhuang Yiling Pharmaceutical
Table Shijiazhuang Yiling Pharmaceutical Influenza Vaccines
Table SK Chemicals
Table SK Chemicals Influenza Vaccines
Table UNM Pharma
Table UNM Pharma Influenza Vaccines
Table Vaccitech
Table Vaccitech Influenza Vaccines
Table Vaxart
Table Vaxart Influenza Vaccines
Table Vaxine Pty
Table Vaxine Pty Influenza Vaccines
Table Visterra
Table Visterra Influenza Vaccines
Table Global Influenza Vaccines Sales by Manufacturer (2016-2017)
Figure Global Influenza Vaccines Sales Market Share by Manufacturer in 2016
Figure Global Influenza Vaccines Sales Market Share by Manufacturer in 2017
Table Global Influenza Vaccines Revenue by Manufacturer (2016-2017)
Figure Global Influenza Vaccines Revenue Market Share by Manufacturer in 2016
Figure Global Influenza Vaccines Revenue Market Share by Manufacturer in 2017
Table Global Influenza Vaccines Price by Manufacturer (2016-2017)
Figure Top 3 Influenza Vaccines Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Influenza Vaccines Manufacturer (Revenue) Market Share in 2017
Figure Global Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure Global Influenza Vaccines Revenue and Growth Rate (2013-2018)
Table Global Influenza Vaccines Sales by Regions (2013-2018)
Table Global Influenza Vaccines Sales Market Share by Regions (2013-2018)
Table Global Influenza Vaccines Revenue by Regions (2013-2018)
Figure Global Influenza Vaccines Revenue Market Share by Regions in 2013
Figure Global Influenza Vaccines Revenue Market Share by Regions in 2017
Figure North America Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure North America Influenza Vaccines Revenue and Growth Rate (2013-2018)
Figure Europe Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure Europe Influenza Vaccines Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Influenza Vaccines Revenue and Growth Rate (2013-2018)
Figure South America Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure South America Influenza Vaccines Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Influenza Vaccines Revenue and Growth Rate (2013-2018)
Figure North America Influenza Vaccines Revenue and Growth Rate (2013-2018)
Table North America Influenza Vaccines Sales by Countries (2013-2018)
Table North America Influenza Vaccines Sales Market Share by Countries (2013-2018)
Figure North America Influenza Vaccines Sales Market Share by Countries in 2013
Figure North America Influenza Vaccines Sales Market Share by Countries in 2017
Table North America Influenza Vaccines Revenue by Countries (2013-2018)
Table North America Influenza Vaccines Revenue Market Share by Countries (2013-2018)
Figure North America Influenza Vaccines Revenue Market Share by Countries in 2013
Figure North America Influenza Vaccines Revenue Market Share by Countries in 2017
Figure United States Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure Canada Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure Mexico Influenza Vaccines Sales and Growth Rate (2013-2018)
Table North America Influenza Vaccines Sales by Manufacturer (2016-2017)
Figure North America Influenza Vaccines Sales Market Share by Manufacturer in 2016
Figure North America Influenza Vaccines Sales Market Share by Manufacturer in 2017
Table North America Influenza Vaccines Revenue by Manufacturer (2016-2017)
Figure North America Influenza Vaccines Revenue Market Share by Manufacturer in 2016
Figure North America Influenza Vaccines Revenue Market Share by Manufacturer in 2017
Table North America Influenza Vaccines Sales by Type (2013-2018)
Table North America Influenza Vaccines Sales Share by Type (2013-2018)
Table North America Influenza Vaccines Revenue by Type (2013-2018)
Table North America Influenza Vaccines Revenue Share by Type (2013-2018)
Table North America Influenza Vaccines Sales by Application (2013-2018)
Table North America Influenza Vaccines Sales Share by Application (2013-2018)
Table North America Influenza Vaccines Revenue by Application (2013-2018)
Table North America Influenza Vaccines Revenue Share by Application (2013-2018)
Figure Europe Influenza Vaccines Revenue and Growth Rate (2013-2018)
Table Europe Influenza Vaccines Sales by Countries (2013-2018)
Table Europe Influenza Vaccines Sales Market Share by Countries (2013-2018)
Table Europe Influenza Vaccines Revenue by Countries (2013-2018)
Figure Europe Influenza Vaccines Revenue Market Share by Countries in 2016
Figure Europe Influenza Vaccines Revenue Market Share by Countries in 2017
Figure Germany Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure UK Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure France Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure Russia Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure Italy Influenza Vaccines Sales and Growth Rate (2013-2018)
Table Europe Influenza Vaccines Sales by Manufacturer (2016-2017)
Figure Europe Influenza Vaccines Sales Market Share by Manufacturer in 2016
Figure Europe Influenza Vaccines Sales Market Share by Manufacturer in 2017
Table Europe Influenza Vaccines Revenue by Manufacturer (2016-2017)
Figure Europe Influenza Vaccines Revenue Market Share by Manufacturer in 2016
Figure Europe Influenza Vaccines Revenue Market Share by Manufacturer in 2017
Table Europe Influenza Vaccines Sales by Type (2013-2018)
Table Europe Influenza Vaccines Sales Share by Type (2013-2018)
Table Europe Influenza Vaccines Revenue by Type (2013-2018)
Table Europe Influenza Vaccines Revenue Share by Type (2013-2018)
Table Europe Influenza Vaccines Sales by Application (2013-2018)
Table Europe Influenza Vaccines Sales Share by Application (2013-2018)
Table Europe Influenza Vaccines Revenue by Application (2013-2018)
Table Europe Influenza Vaccines Revenue Share by Application (2013-2018)
Figure Asia-Pacific Influenza Vaccines Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Influenza Vaccines Sales by Countries (2013-2018)
Table Asia-Pacific Influenza Vaccines Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Influenza Vaccines Sales Market Share by Countries 2017
Table Asia-Pacific Influenza Vaccines Revenue by Countries (2013-2018)
Figure Asia-Pacific Influenza Vaccines Revenue Market Share by Countries 2017
Figure China Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure Japan Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure Korea Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure India Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure Southeast Asia Influenza Vaccines Sales and Growth Rate (2013-2018)
Table Asia-Pacific Influenza Vaccines Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Influenza Vaccines Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Influenza Vaccines Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Influenza Vaccines Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Influenza Vaccines Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Influenza Vaccines Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Influenza Vaccines Sales by Type (2013-2018)
Table Asia-Pacific Influenza Vaccines Sales Share by Type (2013-2018)
Table Asia-Pacific Influenza Vaccines Revenue by Type (2013-2018)
Table Asia-Pacific Influenza Vaccines Revenue Share by Type (2013-2018)
Table Asia-Pacific Influenza Vaccines Sales by Application (2013-2018)
Table Asia-Pacific Influenza Vaccines Sales Share by Application (2013-2018)
Table Asia-Pacific Influenza Vaccines Revenue by Application (2013-2018)
Table Asia-Pacific Influenza Vaccines Revenue Share by Application (2013-2018)
Figure South America Influenza Vaccines Revenue and Growth Rate (2013-2018)
Table South America Influenza Vaccines Sales by Countries (2013-2018)
Table South America Influenza Vaccines Sales Market Share by Countries (2013-2018)
Figure South America Influenza Vaccines Sales Market Share by Countries in 2017
Table South America Influenza Vaccines Revenue by Countries (2013-2018)
Table South America Influenza Vaccines Revenue Market Share by Countries (2013-2018)
Figure South America Influenza Vaccines Revenue Market Share by Countries in 2017
Figure Brazil Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure Argentina Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure Colombia Influenza Vaccines Sales and Growth Rate (2013-2018)
Table South America Influenza Vaccines Sales by Manufacturer (2016-2017)
Figure South America Influenza Vaccines Sales Market Share by Manufacturer in 2016
Figure South America Influenza Vaccines Sales Market Share by Manufacturer in 2017
Table South America Influenza Vaccines Revenue by Manufacturer (2016-2017)
Figure South America Influenza Vaccines Revenue Market Share by Manufacturer in 2016
Figure South America Influenza Vaccines Revenue Market Share by Manufacturer in 2017
Table South America Influenza Vaccines Sales by Type (2013-2018)
Table South America Influenza Vaccines Sales Share by Type (2013-2018)
Table South America Influenza Vaccines Revenue by Type (2013-2018)
Table South America Influenza Vaccines Revenue Share by Type (2013-2018)
Table South America Influenza Vaccines Sales by Application (2013-2018)
Table South America Influenza Vaccines Sales Share by Application (2013-2018)
Table South America Influenza Vaccines Revenue by Application (2013-2018)
Table South America Influenza Vaccines Revenue Share by Application (2013-2018)
Figure Middle East and Africa Influenza Vaccines Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Influenza Vaccines Sales by Countries (2013-2018)
Table Middle East and Africa Influenza Vaccines Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Influenza Vaccines Sales Market Share by Countries in 2017
Table Middle East and Africa Influenza Vaccines Revenue by Countries (2013-2018)
Table Middle East and Africa Influenza Vaccines Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Influenza Vaccines Revenue Market Share by Countries in 2013
Figure Middle East and Africa Influenza Vaccines Revenue Market Share by Countries in 2017
Figure Saudi Arabia Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure UAE Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure Egypt Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure Nigeria Influenza Vaccines Sales and Growth Rate (2013-2018)
Figure South Africa Influenza Vaccines Sales and Growth Rate (2013-2018)
Table Middle East and Africa Influenza Vaccines Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Influenza Vaccines Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Influenza Vaccines Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Influenza Vaccines Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Influenza Vaccines Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Influenza Vaccines Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Influenza Vaccines Sales by Type (2013-2018)
Table Middle East and Africa Influenza Vaccines Sales Share by Type (2013-2018)
Table Middle East and Africa Influenza Vaccines Revenue by Type (2013-2018)
Table Middle East and Africa Influenza Vaccines Revenue Share by Type (2013-2018)
Table Middle East and Africa Influenza Vaccines Sales by Application (2013-2018)
Table Middle East and Africa Influenza Vaccines Sales Share by Application (2013-2018)
Table Middle East and Africa Influenza Vaccines Revenue by Application (2013-2018)
Table Middle East and Africa Influenza Vaccines Revenue Share by Application (2013-2018)
Table Global Influenza Vaccines Sales by Type (2013-2018)
Table Global Influenza Vaccines Sales Share by Type (2013-2018)
Table Global Influenza Vaccines Revenue by Type (2013-2018)
Table Global Influenza Vaccines Revenue Share by Type (2013-2018)
Figure Global Trivalent Flu Vaccines Sales Growth (2013-2018)
Figure Global Trivalent Flu Vaccines Price (2013-2018)
Figure Global Quadrivalent Flu Vaccines Sales Growth (2013-2018)
Figure Global Quadrivalent Flu Vaccines Price (2013-2018)
Table Global Influenza Vaccines Sales by Application (2013-2018)
Table Global Influenza Vaccines Sales Share by Application (2013-2018)
Figure Global Adults Sales Growth (2013-2018)
Figure Global Pediatrics Sales Growth (2013-2018)
Figure Global Influenza Vaccines Sales, Revenue and Growth Rate (2018-2023)
Table Global Influenza Vaccines Sales Forecast by Regions (2018-2023)
Table Global Influenza Vaccines Market Share Forecast by Regions (2018-2023)
Figure North America Sales Influenza Vaccines Market Forecast (2018-2023)
Figure Europe Sales Influenza Vaccines Market Forecast (2018-2023)
Figure Asia-Pacific Sales Influenza Vaccines Market Forecast (2018-2023)
Figure South America Sales Influenza Vaccines Market Forecast (2018-2023)
Figure Middle East and Africa Sales Influenza Vaccines Market Forecast (2018-2023)
Table Global Influenza Vaccines Sales Forecast by Type (2018-2023)
Table Global Influenza Vaccines Market Share Forecast by Type (2018-2023)
Table Global Influenza Vaccines Sales Forecast by Application (2018-2023)
Table Global Influenza Vaccines Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List